The Pharmaceutical Market: Bangladesh - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-13 14:15:03
While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies, such as Bangladesh, may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. With regards to assessing risks in the Bangladeshi healthcare sector, we have identified those emanating from the state´s political/economic profile (such as high inflation) and industry specific dangers (such as low per-capita spending and poor access to healthcare facilities) that call into question the likelihood of anticipated returns being realised over the assessed time period.
Headline Expenditure Projections
Pharmaceuticals : BDT111.10bn (US$1.50bn) in 2011 to BDT124.25bn (US$1.54bn) in 2012; +11.8% in local currency terms and +2.5% in US dollar terms.
Healthcare: BDT271.27bn (US$3.66bn) in 2011 to BDT304.45bn (US$3.76bn) in 2012; +12.2% in local currency terms and +12.8% in US dollar terms.
Medical devices: BDT12.91bn (US$174mn) in 2011 to BTD14.47bn (US$179mn) in 2012; +12.1% in local currency terms and +2.7% in US dollar terms.
Risk/Reward Ratings : While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Bangladesh may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. For Q113, Bangladesh has retained its 17th position out of the 18 regional markets surveyed. Its overall rating of 38.3, remains considerably lower than the average for the region.
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.